CCSD code M7590 – Suburethral tape sling billing guide

Key takeaways

CCSD Code M7590 covers suburethral tape sling insertion (TOT or TVT), with intraoperative cystoscopy included in the same fee.

Surgeon-administered local anaesthetic is bundled within M7590, while a separate anaesthetist’s fee and the mesh tape prosthesis are billed independently.

CCSD lists cystoscopy (M4510, M4514) and surgeon local anaesthetic (AC100) as unacceptable with M7590, and payers may reject or flag them.

Payers usually want pre-authorisation, proof of stress urinary incontinence and failed conservative treatment, so check each payer’s current policy.

Pabau’s claims management supports CCSD-coded claim submission and tracking, with consent forms and clinical notes on the same patient record.

CCSD Code M7590: Official descriptor and what it covers

CCSD Code M7590 has one official descriptor in the CCSD schedule of procedures. It reads: Insertion of suburethral tape sling (e.g. TOT or TVT) +/- administration of local anaesthetic by operating surgeon (including cystoscopy). The single procedure fee bundles three elements.

• Suburethral tape sling insertion: The primary operation, performed via either the transobturator (TOT) or retropubic (TVT) approach. Both sit within a single code.
• Intraoperative cystoscopy: A check cystoscopy performed during the procedure to confirm bladder integrity and correct tape positioning. The descriptor includes it explicitly.
• Local anaesthetic by the operating surgeon: Peri-operative infiltration anaesthesia administered by the performing surgeon. The “+/-” notation signals it is optional, but when the surgeon gives it, it falls within M7590.

M7590 sits in the M-series of the schedule, which covers urinary tract procedures. The CCSD files it under two sub-chapters, 12.3.0 Bladder and 14.2.0 Suspension. The CCSD code library lists the neighbouring codes in the same series.

The CCSD Group’s member payers, Bupa, AXA Health, Aviva and Vitality, use these codes in their fee schedules and pre-authorisation portals. Confirm the code on Bupa’s code search portal before you quote it to a patient.

Clinical procedure: What happens during a suburethral sling insertion

A suburethral tape sling supports the mid-urethra to restore continence in patients with stress urinary incontinence (SUI). Knowing the surgical steps helps practice managers check that operative notes contain the elements payers look for.

The two approaches within CCSD Code M7590 differ in tape routing. TOT passes the tape laterally through the obturator foramen, while TVT passes it retropubically behind the pubic bone. Both are usually day-case procedures under general or spinal anaesthesia. The operating surgeon often adds local anaesthetic infiltration at the tape exit sites.

Surgical steps relevant to billing documentation

1. Anaesthetic induction: General, spinal, or local anaesthetic with sedation. If the surgeon administers local anaesthetic, record it in the operative note, because it falls within M7590.
2. Suburethral incision and dissection: A midline vaginal incision exposes the periurethral tissue at the level of the mid-urethra.
3. Tape passage: The surgeon passes the polypropylene mesh tape via the chosen route (obturator for TOT, retropubic for TVT) using a dedicated introducer needle.
4. Tension adjustment: The surgeon positions the tape without tension under the mid-urethra and confirms it with a cough test or similar dynamic assessment.
5. Intraoperative cystoscopy: A rigid or flexible cystoscope confirms bladder and urethral integrity, rules out tape penetration, and checks ureteric efflux. Record this step in the operative note, because the M7590 fee includes it.
6. Wound closure: Vaginal incision closed with absorbable suture.

Capture each of these steps as a structured field in the clinical note. The payer then finds what it checks at claim submission without querying the surgeon.

TOT vs TVT: Billing implications and code applicability

A single CCSD Code M7590 covers both approaches. There is no separate M-code for TOT versus TVT. The operative note must specify which technique the surgeon used, but you submit the claim under M7590 regardless.

If the surgeon converts from one technique to the other intraoperatively, the operative note should record the conversion, the reason, and the final approach. The claim remains under M7590, and no additional code applies to the technique change itself.

What M7590 includes: Bundled elements you cannot bill separately

The official descriptor makes the inclusions explicit. Billing any of the following separately on the same claim is unbundling, and payers may reject or flag the claim for it.

• Intraoperative cystoscopy: The fee includes the cystoscopy performed to check tape position and bladder integrity. Do not add a cystoscopy-only CCSD code, such as M4510 or M4514, to the same invoice. CCSD lists both as unacceptable with M7590, and payers may reject or flag them.
• Local anaesthetic administered by the operating surgeon: Peri-operative infiltration by the surgeon who performs the sling insertion is within the M7590 fee. CCSD lists AC100, local anaesthetic by the main operator, as unacceptable with M7590. This does not cover a separately contracted anaesthetist providing general or spinal anaesthesia.
• Routine intraoperative checks: Standard surgical assessment steps performed during the sling procedure are part of the surgical episode covered by M7590.

What M7590 does not include: Separately billable items

Several legitimate costs fall outside the M7590 surgery fee, so you must invoice them on their own. Knowing the boundary prevents both under-recovery and inappropriate bundling.

• Mesh tape prosthesis cost: The polypropylene suburethral tape, the implant itself, has its own charge as a prosthesis item. Under standard CCSD billing convention, you bill implant costs independently of the procedure fee. Check the prosthesis guidance in the CCSD technical preamble and confirm with each payer, as some cap prosthesis reimbursement or pre-approve the specific product.
• General or spinal anaesthetist fee: Where a separate anaesthetist provides GA or regional anaesthesia, they submit their own claim. The surgeon billing M7590 covers only their own local anaesthetic within the procedure fee.
• Assistant surgeon fee: If a qualified assistant participates, they bill their fee on its own under the applicable CCSD assistant surgeon tariff.
• Hospital or facility charges: Theatre time, nursing, consumables, and any overnight stay are the hospital’s invoice, separate from the surgeon’s M7590 claim.
• Post-operative consultations: Bill follow-up outpatient visits after the procedure under the relevant consultation code, not M7590.

Primary indication: Stress urinary incontinence and billing justification

Stress urinary incontinence (SUI) is the clinical indication that justifies CCSD Code M7590. SUI is involuntary leakage of urine on effort or exertion, or on sneezing or coughing. Payers ask for proof of the diagnosis before they authorise the procedure.

Urodynamic testing is not always part of that evidence. NICE NG123 advises against multichannel cystometry before primary surgery when SUI is diagnosed from a detailed history and shown on examination. It does recommend urodynamics first for groups such as women with unclear symptoms or previous SUI surgery.

Some payers set their own evidence rules on top of NICE. Check each payer’s current pre-authorisation policy, and attach whatever investigation results it names to the request.

Neighbouring CCSD codes: Avoid confusion and miscoding

Several codes sit close to M7590 in the CCSD bladder and suspension sub-chapters. Some describe a different bladder outlet operation, and CCSD lists others as unacceptable with M7590. The table maps both.

The table covers insertion only. For removal or revision of an existing tape, search the CCSD schedule for the current code before you quote a fee.

The Bupa CCSD billing guide explains how payers interpret adjacent codes across the schedule. For a cystoscopy booked on its own date, M4510 is the flexible cystoscopy code.

Pre-authorisation requirements for M7590

UK private payers usually ask for pre-authorisation before planned surgery such as CCSD Code M7590. Treating without an authorisation reference number puts payment at risk. Requirements vary by payer, so check each one’s current policy, including Bupa, AXA Health, Aviva, and Vitality. A request typically carries the following.

• Proof of SUI: A detailed history and examination, plus urodynamic results where NICE NG123 or the payer calls for them.
• Evidence of failed conservative treatment: Records showing that supervised pelvic floor muscle training was completed and proved inadequate. NICE NG123 recommends a trial of at least 3 months as first-line treatment, so check each payer’s policy for its own minimum.
• Referring clinician letter: A GP or specialist referral letter confirming the diagnosis, duration of symptoms, and that surgical intervention is clinically indicated.
• Mesh governance evidence: Confirmation of the MDT review, consent discussion and registry entry NICE NG123 sets out (see the NICE section below). Check each payer’s current policy for what it asks to see.
• Procedure code and surgeon details: The pre-auth request must specify M7590 and the performing surgeon’s recognition number with the payer.

Record the authorisation number on the patient’s file before you confirm the theatre date. A procedure that goes ahead without it leaves both the practice and the patient exposed if the payer declines.

NICE guidance on mesh sling procedures and its impact on billing

NICE guideline NG123 sets the clinical rules for mesh slings in England. NICE published it in April 2019, after the July 2018 pause on vaginal mesh for SUI. NHS England and NHS Improvement ran that pause as a high vigilance restriction. The Independent Medicines and Medical Devices Safety Review then reported in 2020.

Payers do not publish one shared rule on NG123, but its recommendations shape what a complete M7590 file looks like.

• MDT review: NG123 says local multidisciplinary teams should review the proposed treatment for every woman offered an invasive procedure for primary SUI.
• Route: NICE includes the retropubic mesh sling in the surgical choice. It says not to offer a transobturator approach unless specific clinical circumstances, such as previous pelvic procedures, rule out the retropubic route.
• Consent and implant details: The woman should be told the sling is a permanent implant and complete removal might not be possible. She should also get written details of the implant, its manufacturer, the insertion date and the surgeon.
• Registry and reporting: Providers must record SUI procedures in a national registry, including the mesh material, manufacturer and product identification code. Confirmed mesh complications are also reported to the MHRA.

In England, the facility where M7590 is performed also needs CQC registration for the regulated activity of operations.

Documentation requirements: What operative notes must contain for M7590

An incomplete operative note is a common trigger for post-submission queries on CCSD Code M7590. Payers query claims where the note does not support the elements the descriptor includes. Use this checklist when reviewing notes before claim submission.

Digital consent forms and note templates can prompt for each field as staff write the note. The team then avoids rebuilding a missing element before claim submission.

Common claim denial reasons for M7590 and how to prevent them

Five preventable patterns sit behind most avoidable CCSD Code M7590 rejections and queries.

• Missing pre-authorisation: The surgeon performed the procedure before the payer issued a valid authorisation number, or the pre-auth request quoted the wrong code. Prevention: Confirm the authorisation references M7590 and is in date before the procedure.
• Unbundled cystoscopy: The practice bills M4510 or M4514 with M7590. Prevention: Audit every M7590 invoice for a cystoscopy line on the same date of service and remove it.
• Thin proof: The pre-auth request does not show how SUI was diagnosed, or omits investigation results the payer asked for. Prevention: Check the payer’s current policy and attach what it names.
• Mesh governance evidence absent: The payer cannot see that the NICE NG123 steps were followed. Prevention: Include the signed consent form covering mesh risks, the tape’s product details, and the MDT review in the submission.
• Incomplete operative note: The note does not record the cystoscopy findings, the technique used, or the surgeon’s local anaesthetic. Prevention: Use the records checklist above before finalising and submitting.

How Pabau supports M7590 billing in private urology and gynaecology

An M7590 claim depends on a chain of documents, from the pre-authorisation request through the operative note to the payer claim. When those sit in different systems, the claim waits while someone gathers the evidence.

Pabau, the practice management platform we build, keeps those documents on one patient file. Its claims management software supports CCSD-coded claim submission and tracking through Healthcode, using details already on the patient record.

Urodynamic results, physiotherapy history and the signed consent form sit in the same patient record as the invoice. When a payer queries the claim, the answer is already in one timeline rather than spread across inboxes.

Keep CCSD claims and their evidence together

Pabau supports CCSD-coded claim submission and tracking, with consent forms and clinical notes on the same patient record. See how it fits your urology or gynaecology practice.

Book a demo

Conclusion

M7590 is one code with one fee, so the billing risk sits at its edges. Claims tend to fail on an extra cystoscopy code, a separate local anaesthetic line, or a missing authorisation number.

Build the file before the theatre date: the authorisation number, the MDT review, the signed consent and the implant details NICE NG123 lists. A practice that does this can reduce rejections and audit queries, because the practice answers the payer’s questions before it asks them.

Book a demo to see how Pabau keeps CCSD claims and their evidence on one patient record.

Continue your research

Need to understand how Bupa processes CCSD codes? Bupa CCSD billing guide covers the Bupa fee schedule framework and how to submit CCSD-coded claims correctly.

Billing a standalone flexible cystoscopy? CCSD Code M4510 explains when the cystoscopy code applies on its own date of service.

Coding a colposuspension instead of a tape sling? CCSD Code M5220 covers retropubic bladder neck suspension and how it differs from M7590.

Frequently asked questions